|
7th Annual "Hedge" Golf Invitational
Raises More than $400,000
|
 | |
From Left: Rob Citrone, Dr. Rutherford, Cindy Citrone, Troy Polamalu, Dr. Ratner, Stephanie Ercegovic
|
Thanks to the support of the hedge fund and financial services industries, the seventh annual "Hedge" golf invitational held on Monday, May 19 at the Country Club of Fairfield was the most successful ever. Proceeds support the research and patient well-being programs of Discovery to Cure and the Troy and Theodora Polamalu Foundation's efforts to provide scholarships and sports camps and to meet basic human needs in American Samoa.
The Citrone family generously underwrote all expenses so that one hundred percent of the proceeds were donated to these charitable causes. This financial support will be leveraged by the synergy the event generated between the two beneficiary organizations. After viewing the Polamalu video documenting the basic healthcare needs of the American Samoan people, Drs. Rutherford and Ratner are planning a Discovery to Cure medical mission trip to the island. "There is no reason for people to suffer with diabetes and heart disease, which can be managed with the proper treatment and medications," said Dr. Rutherford. "We can diagnose and treat them and leave each with a year's supply of medications. We are excited about this opportunity to provide relief in American Samoa and grateful for the ongoing partnership of the Citrone family and the hedge fund community in advancing the prevention and treatment of women's reproductive cancers."
|
|
Meet Alessandro Santin, MD
| 
Dr. Santin is a skilled gynecologic oncologist and talented clinical scientist who has a strong background in training and mentoring talented young physician-scientists. Dr. Santin's research and clinical accomplishments have been published in high-impact journals in the cancer research field, including the New England Journal of Medicine, Cancer Research, Clinical Cancer Research,
PNAS and the Journal of Virology, while numerous additional publications have been reported in subspecialty journals.
Dr. Santin's translational research program in
gynecologic tumors has been funded multiple times by federal agencies, including the Department of Defense (DoD), the National Institutes of Health (NIH) as well as private national and international foundations. He is currently funded by NIH to evaluate
the underlying biological differences associated with racial disparities in the survival of women diagnosed with biologically aggressive endometrial cancers as well as the potential use of Clostridium Perfringens Enterotoxin (CPE) as a novel therapy against chemotherapy resistant ovarian
tumors. His research program spans a range from basic studies in molecular cancer genetics and tumor immunology to translational clinical cancer research testing novel immunotherapeutic strategies and targeted compounds in vivo for the treatment of gynecologic malignancies.
Read more about Dr. Santin's research here.
Read about Dr. Santin's research targeting uterine serous carcinoma here.
|
|
Pink Aid Awards Discovery to Cure $5,000 for Breast and Ovarian Cancer Prevention
| |
Discovery to Cure received a $5,000 grant from Pink Aid to fund its Breast and Ovarian Cancer Prevention Program, which couples outreach to women at high risk, with genetic testing and cutting edge cancer risk management. The ultimate goal is to prevent breast and ovarian cancer among those at high risk due to BRCA1 or BRCA2 mutation. Elena Ratner, MD and Erin Wysong Hofstatter, MD are the principle investigators. "We are very grateful for this grant which will allow us to provide genetic testing to high-risk, underserved women who otherwise could not afford it," said Dr. Ratner. "We hope the grant also represents the start of a trend recognizing that these diseases run together and that effective prevention protocols can prevent both diseases and save lives."
|
|
|
| |
SAVE THE DATE
Wednesday, June 18
6:00 p.m. -8:00 p.m.
284 York Street
New Haven
RSVP
| |
5:00 p.m.- 8:00 p.m.
2630 Whitney Ave
Hamden
RSVP
Meredith Pacelli
203-415-5659
15% of Alex & Ani sales and 100% of happy hour proceeds benefit
Join us on
Sunday, September 28
for this walk to
End Women's Cancers
|
|
| |
Discovery to Cure advances the prevention, early detection and treatment of women's reproductive cancers.
Would you like to get involved in the lifesaving work of
Discovery to Cure?
We welcome volunteers to help us with special events and community outreach.
For more information
Please consider forwarding this e-mail to a friend. |
|
|
